Journal of Neuroinflammation (Mar 2010)

Membrane attack complex inhibitor CD59a protects against focal cerebral ischemia in mice

  • Nietfeld Wilfried,
  • Dirnagl Ulrich,
  • Morgan B Paul,
  • Stahel Philip F,
  • Khojasteh Uldus,
  • Harhausen Denise,
  • Trendelenburg George

DOI
https://doi.org/10.1186/1742-2094-7-15
Journal volume & issue
Vol. 7, no. 1
p. 15

Abstract

Read online

Abstract Background The complement system is a crucial mediator of inflammation and cell lysis after cerebral ischemia. However, there is little information about the exact contribution of the membrane attack complex (MAC) and its inhibitor-protein CD59. Methods Transient focal cerebral ischemia was induced by middle cerebral artery occlusion (MCAO) in young male and female CD59a knockout and wild-type mice. Two models of MCAO were applied: 60 min MCAO and 48 h reperfusion, as well as 30 min MCAO and 72 h reperfusion. CD59a knockout animals were compared to wild-type animals in terms of infarct size, edema, neurological deficit, and cell death. Results and Discussion CD59a-deficiency in male mice caused significantly increased infarct volumes and brain swelling when compared to wild-type mice at 72 h after 30 min-occlusion time, whereas no significant difference was observed after 1 h-MCAO. Moreover, CD59a-deficient mice had impaired neurological function when compared to wild-type mice after 30 min MCAO. Conclusion We conclude that CD59a protects against ischemic brain damage, but depending on the gender and the stroke model used.